Model of 'The Pharmaceutical Channel' Demonstrates Clinical Trial Management
Application
NEW YORK, July 18 /PRNewswire/ --
Intrasphere Technologies today announced the launch of The Pharmaceutical Channel (TPC), an enterprise information portal for the pharmaceutical industry.
The Pharmaceutical Channel provides a single focal point for company and non-company resources by aggregating business information, linking users to public websites and syndicated data and integrating back office applications.
TPC is capable of linking investigators, CRAs, medical monitors, clinical managers and product managers within a single, central electronic environment that integrates multiple clinical development technologies with a broad range of business applications.
Among other benefits to pharmaceutical companies, The Pharmaceutical Channel is a dynamic clinical trial management tool for all key stakeholders in the clinical trial management process.
Clinical Trial Management Applications
Clinical trial management applications available under The Pharmaceutical Channel include:
-- Clinical Trial Management -- TPC provides access to a rich matrix of
information concerning enrollment, payments, project milestones,
discrepancies and budget information. TPC's sophisticated security
model supports discrete views of the data by individual audiences.
-- Electronic Data Capture (EDC) -- TPC enables integrated access to a
full range of EDC technology. Links into the EDC database allow TPC
to surface critical data such as safety issues. The links also
facilitate cross-platform reporting and enable automatic notification
triggers via email or phone. Intrasphere also provides EDC process
and integration services as a separate offering.
-- Clinical Data Management -- Intrasphere integrates clinical data
management systems with other mission-critical applications used in
the clinical trial process. These applications run transparently
inside TPC, facilitating sophisticated real-time data mining and
reporting in textual or graphical format.
-- On-line Collaboration -- TPC enables live, on-line meetings between
all players in the clinical trials chain. This interactive
collaboration, available through video, voice and application sharing,
leads to multiple benefits including greater participation by offsite
participants (internal and external), maintaining project continuity
when clinical professionals change and creating audit trails
monitoring usage and performance to validate learning in support of
the Guidance and 21 CFR Part 11.
-- Document Management and Secure Document Exchange -- TPC incorporates
both document management and secure document exchange technologies
from best-of-breed vendors. These applications are crucial to
providing the manageable, auditable services required by new
regulatory reporting standards as well as adhering to best practices.
A full demonstration of The Pharmaceutical Channel is available by contacting Joel Hoffmann, Intrasphere Technologies Inc., 212 937-8270 or joel.hoffman@Intrasphere.com.
Background: Information Enterprise Portals
Increasingly used in information-intensive industries, enterprise information portals can greatly enhance communication channel and information- sharing capabilities. They provide an innovative, central electronic approach to managing day-to-day back office, eBusiness and eCommerce activities. They can enable employees to self-administer many processes from any location, and they can connect company managers to relevant business data through a digital dashboard that can be customized for their information requirements.
About Intrasphere Technologies
Intrasphere Technologies, Inc. provides technology solutions to companies seeking to maximize their Internet, Intranet and Extranet business space. The company specializes in application development and systems integration for the pharmaceutical and finance industries. Headquarters are at 100 Broadway, New York City, with a second office in London. The company maintains a Website at www.Intrasphere.com.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X73811373
